REPO4EU, is the Euro/Global Platform for Drug Repurposing from imprecise drug therapy to AI-powered precision medicine, has selected Stalicla as a partner & awarded them with 1.7 EUR M.
The award is yet another validation of Stalicla in-house neurodevelopmental disorder-specific precision medicine discovery platform (DEPI).
Congrats team!